Weekly Healthcare Policy Round-Up

In this week’s Health Policy Round-Up, ALF shares the most up to date news happening in Washington DC.

• During National Liver Awareness Month, American Liver Foundation hosted the MASH: Empower and Educate Summit in Chicago Illinois. ALF brought together 30 liver patients to raise awareness about MASH. This two-day event empowered patients and caregivers through robust education, storytelling, and media training. ALF was honored to bring together so many people for an engaging weekend! Read our press release to learn more about the event.
• National Liver Awareness Month may be coming to an end, but there’s still time to speak up for liver health. Join us in urging lawmakers to prioritize liver health and support policies that improve the lives of those affected by liver disease. Take action here!
• American Liver Foundation celebrates the Food and Drug Administration’s (FDA) approval of Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, for the treatment of chronic hepatitis B virus (HBV) infection! Hibsago is approved for eligible adults who have been receiving HBV antiviral therapy for at least six months, have suppressed levels of HBV in their blood, and have hepatitis B surface antigen levels of 3,000 IU/mL or less. This approval represents an important advancement for people living with chronic hepatitis B and underscores the continued progress being made toward improving treatment options and long-term outcomes for individuals affected by liver disease. Learn more here!
• Election Day is Tuesday, November 3rd. Make your voting plan today, your voice matters!Explore ALF’s Election Center here.
• The Affordable Care Act open enrollment period begins Sunday November 1st and remains open through January 15, 2027. If you or someone you know is looking for health insurance through the Marketplace, visit HealthCare.gov to learn more about available plans and find the coverage that’s right for you.